Merial, the animal health arm of Sanofi (SNY), delivered double-digit growth in 2Q15. Merial reported total revenues of 691 million euros, a 14.2% increase at constant exchange rates over 2Q14. Merial ...

Merial, the animal health arm of Sanofi (SNY) delivered double-digit growth in 1Q16. Merial reported total revenues of 760 million euros, a 17.5% increase at constant exchange rates over 1Q15 revenues ...

DULUTH, Ga., Feb. 16 /PRNewswire/ -- Merial, a world-leading animal health company, has gained full-licensure from the U.S. Department of Agriculture for ONCEPT™ Canine Melanoma Vaccine, DNA. ONCEPT ...

An Indian veterinary clinic employee gives a rabies vaccination to a pet dog at a free vaccination camp at the Government Super Speciality Veterinary Hospital on the occasion of World Zoonoses Day in ...

French drugmaker Sanofi-Aventis expanded its animal health business by buying the other half of Merial from its U.S. partner Merck for $4 billion in cash while opening the door for a bigger deal. They ...

DULUTH, Ga., Jan. 18, 2016 /PRNewswire/ -- Merial today announced the launch of www.RabiesAware.org, a national rabies information resource for the veterinary profession, at the 2016 North American ...

Merial and Boehringer Ingelheim Vetmedica Inc announced a long-term strategic alliance for their animal health business in the United States. Under the terms of the agreement, Merial will have ...

Sanofi ($SNY) has made a big investment in Brazil, buying the nation's largest generics manufacturer, Genfar, in 2012 to get a stronger foothold not only in human ...

When animal healthcare giant Merial decided to centralize its key business applications, the project spawned a handful of related IT projects, including a WAN optimization deployment designed to boost ...

PARIS, July 30 (Reuters) - French drugmaker Sanofi-Aventis SA expanded its animal health business by buying the other half of Merial from its U.S. partner Merck & Co Inc for $4 billion in cash while ...